Renal protection by a dual ET(A)/ET(B) endothelin antagonist, L-754,142, after aortic cross-clamping in the dog

Journal of the American Society of Nephrology

Volumn 8, Issue 7, 1997, Pages 1061-1071

  Krause, Stephen M ^a   Walsh, Thomas F ^a   Greenlee, William J ^a   Ranaei, Robert ^a   Williams, David L ^a   Kivlighn, Salah D ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN; ENDOTHELIN RECEPTOR ANTAGONIST; L 754142; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA CLAMPING; ARTICLE; CONTROLLED STUDY; DOG; DRUG EFFECT; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; KIDNEY DISEASE; KIDNEY FAILURE; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0030761334     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Carlson DE, Karp RB, Kouchoukos NT: Surgical treatment of aneurysms of the descending thoracic aorta: An analysis of 85 patients. Ann Thorac Surg 35: 58-69, 1983
2. Paul MD, Mazer CD, Byrick RJ, Rose DK, Goldstein MB: Influence of mannitol and dopamine on renal function during elective infrarenal aortic clamping in man. Am J Nephrol 6: 427-434, 1986
3. Berisa F, Beaman M, Adu D, McGonigle JS, Michael J, Downing R, Fielding JWL, Dunn J: Prognostic factors in acute renal failure following aortic aneurysm surgery. Q J Med 279: 689-698, 1990
4. Baldwin L, Henderson A, Hickman P: Effect of postoperative low-dose dopamine on renal function after elective major vascular surgery. Ann Intern Med 120: 744-747, 1994
5. Kellerman PS: Perioperative care of the renal patient. Arch Intern Med 154: 1674-1688, 1994
6. Roberts AJ, Nora JD, Hughes WA, Quintanilla AP, Ganote CE, Sanders JH, Moran JM, Michaelis LL: Cardiac and renal responses to cross-clamping of the descending thoracic aorta. J Thorac Cardiovasc Surg 86: 732-741, 1983
7. Stingo AJ, Clavell AL, Aarhus LL, Burnett JC: Biological role for the endothelin-A receptor in aortic cross-clamping. Hypertension 22: 62-66, 1993
8. Garcia NH, Garvin JL: Endothelin's biphasic effect on fluid reabsorption in the proximal straight tubule and its inhibitory cascade. J Clin Invest 93: 2572-2577, 1994
9. Pass LJ, Eberhart RC, Brown JC, Rohn GN, Estrera AS: The effect of mannitol and dopamine on the renal response to thoracic aortic cross-clamping. J Thorac Cardiovasc Surg 95: 608-612, 1995
10. Sandok EK, Lerman A, Stingo AJ, Perrella MA, Gloviczki P, Burnett JC: Endothelin in a model of acute renal dysfunction: Modulating action of atrial natriuretic factor. J Am Soc Nephrol 3: 196-202, 1992
11. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988
12. Chou S, Dahhan A, Porush JG: Renal actions of endothelin: Interactions with prostacyclin. Am J Physiol 259: F645-F652, 1990
13. Miura K, Yukimura T, Yamashita Y, Shimmen T, Okumura M, Yamanaka S, Imanishi M, Yamamoto K: Renal and femoral vascular responses to endothelin-1 in dogs: Role of prostaglandins. J Pharmacol Exp Ther 256: 11-17, 1991
14. Lerman A, Hildebrand FL, Aarhus L, Burnett JC: Endothelin has biological actions at pathophysiological concentrations. Circulation 83: 1808-1814, 1991
15. Kon V, Yoshioka T, Fogo A, Ichikawa I: Glomerular actions of endothelin in vivo. J Clin Invest 83: 1762-1767, 1989
16. López-Farré A, Gómez-Garre D, Bernabeu F, López-Novoa JM: A role for endothelin in the maintenance of post-ischemic renal failure in the rat. J Physiol (Lond) 444: 513-522, 1991
17. Brooks DP, DePalma PD, Pullen M, Nambi P: Characterization of canine endothelin receptor subtypes and their function. J Pharmacol Exp Ther 268: 1091-1097, 1994
18. Williams DL Jr, Murphy KL, Nolan NA, O'Brien JA, Pettibone DJ, Kivlighn SD, Krause SM, Lis EV, Zingaro GJ, Gabel RA, Clayton FC, Siegl PKS, Zhang K, Naue J, Vyas K, Walsh TF, Fitch KJ, Chakravarty PK, Greenlee BV, Clineschmidt BV: Pharmacology of L-754,142, a highly potent, orally active, non-peptidyl endothelin antagonist. J Pharmacol Exp Ther 275: 1518-1526, 1995
19. Chou S, Porush JG: Renal actions of endothelin-1 and endothelin-3: Interactions with the prostaglandin system and nitric oxide. Am J Kidney Dis 26: 116-123, 1995
20. Shapiro JI, Cheung C, Itabashi A, Chan L, Schrier RW: The effect of verapamil on renal function after warm and cold ischemia in the isolated rat kidney. Transplantation 40: 596-600, 1985
21. Brezis M, Rosen S, Silva P, Epstein FH: Renal ischemia: A new perspective. Kidney Int 26: 375-383, 1984
22. Terada Y, Tomita K, Nonoguchi H, Marumo F: Different localization of two types of endothelin receptor mRNA in microdissected rat nephron segments using reverse transcription and polymerase chain reaction assay. J Clin Invest 90: 107-112, 1992
23. Cristol JP, Warner TD, Thiemermann C, Vane JR: Mediation via different receptors of the vasoconstrictor effects of the endothelins and sarafotoxins in the systemic circulation and renal vasculature of the anesthetized rat. Br J Pharmacol 108: 776-779, 1993
24. B receptor mediates both vasodilation and vasoconstriction in vivo. Biochem Biophys Res Commun 186: 867-873, 1992
25. McMurdo L, Corder R, Thiemermann C, Vane JR: Incomplete inhibition of the pressor effects of endothelin-1 and related peptides in the anesthetized rat with BQ-123 provides evidence for more than one vasoconstrictor receptor. Br J Pharmacol 108: 557-561, 1993
26. Gellai M, DeWolf R, Pullen M, Nambi P: Distribution and functional role of renal ET receptor subtypes in normotensive and hypertensive rats. Kidney Int 46: 1287-1294, 1996
27. Chan I, Chittinandana A, Shapiro JI, Shanley PF, Schrier RW: Effect of an endothelin-receptor antagonist on ischemic acute renal failure. Am J Physiol 266: F135-F138, 1994
28. Fukuroda T, Fujikawa T, Ozaki S, Ishikawa K, Yano M, Nishikibe M: Clearance of circulating endothelin-1 by ETB receptors in rats. Biochem Biophys Res Commun 199: 1461-1465, 1994
29. B -mediated regulation of extracellular levels of endothelin-1 in cultured human endothelial cells. Biochem Biophys Res Commun 209: 483-489, 1995
30. VanHoutte PM, Boulanger CM, Mombouli JV: Endothelium-derived relaxing factors and converting enzyme inhibition. Am J Cardiol 76: 3E-12E, 1995
31. Tokunga O, Yamada T, Fan J, Watanabe T: Age-related decline in prostacyclin synthesis by human aortic endothelial cells. Am J Pathol 138: 941-949, 1991
32. Lüscher TF, Wenzel RR: Endothelin and endothelin receptor antagonists: Pharmacology and clinical implications. Agents Actions 45: 236-253, 1995
33. Brooks DP, DePalma PD, Gellai M, Nambi P, Ohlstein EH, Elliot JD, Gleason JG, Ruffolo RR Jr: Nonpeptide endothelin receptor antagonists. III. Effect of SB209670 and BQ-123 on acute renal failure in anesthetized dogs. J Pharmacol Exp Ther 271: 769-775, 1994
34. Najafi H, Javid H, Hunter J, Serry C, Monson D: Descending aortic aneurysmectomy without adjuncts to avoid ischemia. Ann Thorac Surg 30: 326-335, 1980